This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer
Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells
Exploring and exploiting aberrant RBX1 expression in high-grade serous ovarian cancer
